Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Peter Cashion Joins The Pancreatic Cancer Action Network Board Of Directors

Pancreatic Cancer Action Network
Posted on: 12 Dec 17
Peter Cashion Joins The Pancreatic Cancer Action Network Board Of Directors

PR Newswire

MANHATTAN BEACH, Calif., Dec. 12, 2017

MANHATTAN BEACH, Calif., Dec. 12, 2017 /PRNewswire-USNewswire/ -- The Pancreatic Cancer Action Network (PanCAN) is proud to announce that Peter Cashion, MBA, has been elected to its Board of Directors. In his new leadership role in the fight against the world's toughest cancer, Cashion brings over 20 years' experience with the International Finance Corporation as a chief investment officer and equity head.


Cashion's late wife, Andra Tamburro, was diagnosed with pancreatic cancer in January 2013 and died from the disease in September of that same year. Cashion resides in Washington, D.C., where he lives with his two sons. He has been an avid volunteer and fundraiser for PurpleStride, the walk to end pancreatic cancer, serving as a team captain. Over the last five years Cashion has raised more than $180,000.

"My hope in joining the PanCAN Board of Directors is to ensure that no one has to experience the loss that my family and I did," said Cashion. "I want to use my voice so that people can see that we can fight back against this disease in a positive and productive way."

Cashion received his bachelor's degree from the University of Western Ontario and received his Master of Business Administration (MBA) from Queens University, also in Canada.  

"Peter's leadership and professional experience, coupled with his passion to fight this disease, bring tremendous value to our Board of Directors," said Julie Fleshman, JD, MBA, president and CEO of PanCAN. "Peter's expertise strengthens our organization, and we couldn't be more pleased to welcome him into this role."

The Pancreatic Cancer Action Network has an urgent goal to improve outcomes for patients battling the disease today and double survival by 2020. This work is supported by critical initiatives, including Precision PromiseSM, Know Your Tumor® and the Patient Registry.

Support the Pancreatic Cancer Action Network's urgent goal to double survival by 2020. Follow the Pancreatic Cancer Action Network on Twitter, Instagram and Facebook.

About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.

Media Contact:
Andrew McLean              
Media Relations Specialist
Pancreatic Cancer Action Network
Direct: 310-706-3357, ext. 3516

View original content with multimedia:

SOURCE Pancreatic Cancer Action Network

PR Newswire

Last updated on: 12/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.